World Library  
Flag as Inappropriate
Email this Article

Zatosetron

Article Id: WHEBN0018587059
Reproduction Date:

Title: Zatosetron  
Author: World Heritage Encyclopedia
Language: English
Subject: Halothane, Azasetron, Dazopride, Batanopride, Ramosetron
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Zatosetron

Zatosetron
Systematic (IUPAC) name
5-​chloro-​2,2-​dimethyl-​N-​(8-​methyl-​8-​azabicyclo​[3.2.1]oct-​3-​yl)-​2,3-​dihydro-​1-​benzofuran-​7-​carboxamide
Clinical data
Legal status
?
Identifiers
CAS number
ATC code None
PubChem
ChemSpider
UNII  YesY
Chemical data
Formula C19H25ClN2O2 
Mol. mass 348.867 g/mol
 YesY   

Zatosetron (LY-277,359) is a drug which acts as an antagonist at the 5HT3 receptor[1] It is orally active and has a long duration of action, producing antinauseant effects but without stimulating the rate of gastrointestinal transport.[2][3] It is also an effective anxiolytic in both animal studies and human trials,[4] although with some side effects at higher doses.[5][6]

References

  1. ^ Cohen, ML; Bloomquist, W; Gidda, JS; Lacefield, W (1990). "LY277359 maleate: a potent and selective 5-HT3 receptor antagonist without gastroprokinetic activity". The Journal of Pharmacology and Experimental Therapeutics 254 (1): 350–5.  
  2. ^ Robertson, DW; Lacefield, WB; Bloomquist, W; Pfeifer, W; Simon, RL; Cohen, ML (1992). "Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships". Journal of Medical Chemistry 35 (2): 310–9.  
  3. ^ Schwartz, SM; Goldberg, MJ; Gidda, JS; Cerimele, BJ (1994). "Effect of zatosetron on ipecac-induced emesis in dogs and healthy men". Journal of clinical pharmacology 34 (3): 250–4.  
  4. ^ Smith, WT; Londborg, PD; Blomgren, SL; Tollefson, GD; Sayler, ME (1999). "Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety". Journal of Clinical Psychopharmacology 19 (2): 125–31.  
  5. ^ Williams, PD; Calligaro, DO; Colbert, WE; Helton, DR; Shetler, T; Turk, JA; Jordan, WH (1991). "General pharmacology of a new potent 5-hydroxytryptamine antagonist". Arzneimittel-Forschung 41 (3): 189–95.  
  6. ^ Bendele, A; Means, J; Shoufler, J; Schmalz, C; Hanasono, G; Symanowski, J; Adams, E (1995). "Chronic toxicity of zatosetron, a 5-HT3 receptor antagonist, in rhesus monkeys". Drug and chemical toxicology 18 (1): 61–82.  



This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.